These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11072192)

  • 21. Kinetics and mechanisms of vinpocetine degradation in aqueous solutions.
    Muhammad N; Adams G; Lee HK
    J Pharm Sci; 1988 Feb; 77(2):126-31. PubMed ID: 3361427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality control of liposomal lipids with special emphasis on peroxidation of phospholipids and cholesterol.
    Lang JK; Vigo-Pelfrey C
    Chem Phys Lipids; 1993 Sep; 64(1-3):19-29. PubMed ID: 8242833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of desmopressin loaded in liposomes.
    Law SL; Huang KJ; Chou VH
    J Liposome Res; 2003 Nov; 13(3-4):269-77. PubMed ID: 14670232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
    Pramar Y; Gupta VD
    J Pharm Sci; 1991 Jun; 80(6):551-3. PubMed ID: 1941547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum.
    Silvander M; Johnsson M; Edwards K
    Chem Phys Lipids; 1998 Dec; 97(1):15-26. PubMed ID: 10081146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Damage to liposomal lipids: protection by antioxidants and cholesterol-mediated dehydration.
    Samuni AM; Lipman A; Barenholz Y
    Chem Phys Lipids; 2000 Apr; 105(2):121-34. PubMed ID: 10823461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions.
    Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
    Int J Pharm; 2013 May; 448(2):390-3. PubMed ID: 23541985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation kinetics of water-insoluble lauroyl-indapamide in aqueous solutions: prediction of the stabilities of the drug in liposomes.
    Suo XB; Deng YJ; Zhang H; Wang YQ
    Arch Pharm Res; 2007 Jul; 30(7):876-83. PubMed ID: 17703741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of ionic strength on liposome-buffer and 1-octanol-buffer distribution coefficients.
    Austin RP; Barton P; Davis AM; Manners CN; Stansfield MC
    J Pharm Sci; 1998 May; 87(5):599-607. PubMed ID: 9572911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation kinetics of metronidazole in solution.
    Wang DP; Yeh MK
    J Pharm Sci; 1993 Jan; 82(1):95-8. PubMed ID: 8429500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buffer solutions in drug formulation and processing: How pK
    Samuelsen L; Holm R; Lathuile A; Schönbeck C
    Int J Pharm; 2019 Apr; 560():357-364. PubMed ID: 30797864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of phosphatidylcholine in liposomes containing carboplatin in dependence on composition and storage conditions.
    Pietzyk B; Henschke K
    Int J Pharm; 2000 Mar; 196(2):215-8. PubMed ID: 10699721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Egg phosphatidylcholine liposomes incorporating hydrophobically modified chitosan: pH-sensitive release.
    Hong YJ; Kim JC
    J Nanosci Nanotechnol; 2011 Jan; 11(1):204-9. PubMed ID: 21446428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
    Mayer LD; Tai LC; Ko DS; Masin D; Ginsberg RS; Cullis PR; Bally MB
    Cancer Res; 1989 Nov; 49(21):5922-30. PubMed ID: 2790807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic study on the chemical stability of ifosfamide.
    Kaijser GP; Beijnen JH; Bult A; Hogeboom MH; Underberg WJ
    J Pharm Biomed Anal; 1991; 9(10-12):1061-7. PubMed ID: 1822174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability.
    Zhu H; Meserve K; Floyd A
    Drug Dev Ind Pharm; 2002; 28(2):135-42. PubMed ID: 11926357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP)-a potential antitumour agent.
    Maclean DS; Khokhar AR; Tyle P; Perez-Soler R
    J Microencapsul; 2000; 17(3):307-22. PubMed ID: 10819419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol.
    Shao Y; Zhang C; Yao Q; Wang Y; Tian B; Tang X; Wang Y
    Eur J Pharm Sci; 2014 Feb; 52():1-11. PubMed ID: 24153395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.